8 Results for "

HCV genotypes 5a

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "HCV genotypes 5a" in MCE Product Catalog:

11
11 Cited Publications
Cat. No.: HY-15789
CAS No.: 1370468-36-2
Purity:  99.97%
Synonyms: MK-8742
Target:  

HCV

Research Areas:  

Infection

Elbasvir (MK-8742) is a hepatitis C virus nonstructural protein 5A (HCV NS5A) inhibitor with EC50s of 4, 3 and 3 nM against genotype 1a, 1b, and 2a, respectively.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-12530
CAS No.: 1377049-84-7
Purity:  99.57%
Synonyms: GS-5816
Target:  

HCV SARS-CoV

Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-12530R
CAS No.: 1377049-84-7
Synonyms: GS-5816 (Standard)
Velpatasvir (Standard) is the analytical standard of Velpatasvir. This product is intended for research and analytical applications. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-15789R
CAS No.: 1370468-36-2
Synonyms: MK-8742 (Standard)
Target:  

Reference Standards HCV

Research Areas:  

Infection

Elbasvir (Standard) is the analytical standard of Elbasvir. This product is intended for research and analytical applications. Elbasvir (MK-8742) is a hepatitis C virus nonstructural protein 5A (HCV NS5A) inhibitor with EC50s of 4, 3 and 3 nM against genotype 1a, 1b, and 2a, respectively.
loading...
    loading...
Cat. No.: HY-12530S1
Synonyms: GS-5816-d33
Velpatasvir-d3 (GS-5816-d3) is deuterium labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-125182
CAS No.: 2649904-85-6
Target:  

Cyclophilin HCV

Research Areas:  

Infection

SMCypI C31 is a non-peptidic cyclophilin inhibitor with potent peptidyl-prolyl cis/trans isomerases (PPIase) inhibitory activity (IC50 of 0.1 µM). SMCypI C31 shows pangenotype anti-HCV activity with EC50s ranging from 1.20 to 7.76 μM for genotype 1a, 1b, 2a, 3a, and 5a HCV subgenomic replicons (HCV-SGRs) and chimeric genotype 2a/4a HCV-SGRs. SMCypI C31 disrupts the cyclophilin A-NS5A interaction .
loading...
    loading...
Cat. No.: HY-W749691
Synonyms: (S)-GS-5816-13C,d3
(S)-Velpatasvir- 13C,d3 ((S)-GS-5816- 13C,d3) is 13C labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-12530S3
Synonyms: GS-5816-13C,d3
Velpatasvir- 13C,d3 (GS-5816- 13C,d3) is 13C and deuterium labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...